SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-17-002665
Filing Date
2017-04-17
Accepted
2017-04-17 16:14:41
Documents
1
Period of Report
2017-06-15

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2231732zpre14a.htm PRE 14A 838373
  Complete submission text file 0001047469-17-002665.txt   839606
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 000-15006 | Film No.: 17764710
SIC: 2835 In Vitro & In Vivo Diagnostic Substances